Rights and permissions
About this article
Cite this article
GPIIb-IIIa antagonists cost effective in acute coronary syndromes. Pharmacoecon. Outcomes News 499, 4 (2006). https://doi.org/10.2165/00151234-200604990-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200604990-00008